Skip to main content
Clinical Trials/DRKS00003878
DRKS00003878RecruitingNot Applicable

Quality of life of patients undergoing anallogeneic stem cell transplantation

Klinik für Tumorbiologie0 sites600 target enrollmentStarted: June 1, 2012Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Sponsor
Enrollment
600

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
19 Years to 99 Years (—)
Sex
All

Inclusion Criteria

  • all patients who will be treated with an allogeneic stem cell transplantation after conventional or reduced intensity conditioning
  • -age = 18 years
  • -able to understand the intention of the study aims and to give informed consent
  • -able to understand and to complete the questionnaires

Exclusion Criteria

  • -patients younger than 18 years
  • -lack of informed consent
  • -patients who do not continue to the transplant
  • -no MED A data submitted to the EBMT
  • -patients transplanted for solid tumors
  • -patients participating in another quality of life study during the same period of time

Investigators

Sponsor
Klinik für Tumorbiologie

Similar Trials